Lethal injection

Experts Express Concern About Nevada Execution Drugs

Written on Wednesday, November 22nd, 2017 by Kimberly DelMonico
Filed under: Expert Opinions

Nevada officials would like to use a new combination of drugs for the state’s first execution in more than a decade. Lethal injection experts around the country are expressing their concern.

The Original Protocol

In 1977, Oklahoma became the first state to adopt lethal injection execution. The three-drug protocol, developed by Dr. Jay Chapman, included the sedative sodium thiopental, a paralytic pancuronium bromide, and potassium chloride to stop the heart. Other states implemented similar protocols for lethal injection using these same drugs. However; in recent years, many pharmaceutical companies have stopped manufacturing and selling these drugs, causing a shortage. In some cases, companies that make life-saving drugs refused to export drugs to the United States that would be used to end lives.

As the original protocol was no longer available, states have had to devise new protocols for lethal injection execution. The protocols require the inmate be rendered unconscious before administering drugs that could cause unnecessary pain and suffering. Megan McCracken, attorney for the Death Penalty Clinic at UC-Berkeley School of Law explains, “From a legal perspective, we know it’s beyond question that if the person is conscious or aware, that would lead to an excruciating death. . . . That would violate the Constitution.”

New Injection Protocol

Nevada’s new protocol includes the sedative diazepam, the painkiller fentanyl, and the paralytic cisatracurium.  Diazepam is intended to induce sleep, fentanyl will depress breathing to cause death, and cisatracurium is intended to make death a certainty.  None of these drugs have been used in executions before. This new protocol was developed by Nevada’s chief medical officer, an anesthesiologist. The chief medical officer resigned two weeks ago, but said that his resignation had nothing to do with executions.

The new protocol was scheduled to be used in the execution of Scott Raymond Dozier. A stay of execution was filed and the district court judge ruled that the execution could go forward, but only with diazepam and fentanyl. The state attorney general’s office has said that it will appeal to the Nevada Supreme Court.

The Controversy

If this drug combination works without complications, the protocol could be used by other states as an alternative execution method. However, experts are not convinced that the new protocol will work.

Deborah Denno, a lethal injection expert and law professor at Fordham University, says, “It’s an experiment. . . . It sounds like a high-risk venture. Even trained people can’t claim to know what’s going to happen.” One risk is that the combination of diazepam and a high dose of fentanyl could cause complications such as vomiting.

Jonathan Groner, an Ohio surgeon and lethal injection expert, is concerned that using a paralytic as part of the combination could prevent body movements and disguise any suffering that the inmate may be experiencing. Groner said that the paralytic “pretty much ensures that if an execution is botched, we won’t know it.”

Another concern is that, if anything goes wrong with the first two drugs and the inmate is still alive when the paralytic is administered, he could be aware and unable to move as he suffocates. Dr. David Waisel, a Harvard University anesthesiology professor and expert witness, stated that this “would be a horrific experience.”

About Kimberly DelMonico

Kimberly DelMonico is a licensed attorney in New York and Nevada. She received her law degree from William S. Boyd School of Law at University of Nevada, Las Vegas and her undergraduate degree from New York University, where she studied psychology and broadcast journalism.

About Kimberly DelMonico

Kimberly DelMonico is a licensed attorney in New York and Nevada. She received her law degree from William S. Boyd School of Law at University of Nevada, Las Vegas and her undergraduate degree from New York University, where she studied psychology and broadcast journalism.